Order Article Reprints

Lorenzo MM, Marín-López A, Chiem K, Jimenez-Cabello L, Ullah I, Utrilla-Trigo S, Calvo-Pinilla E, Lorenzo G, Moreno S, Ye C, et al. Vaccinia Virus Strain MVA Expressing a Prefusion-Stabilized SARS-CoV-2 Spike Glycoprotein Induces Robust Protection and Prevents Brain Infection in Mouse and Hamster Models. Vaccines. 2023; 11(5):1006. https://doi.org/10.3390/vaccines11051006

Lorenzo, María M., Alejandro Marín-López, Kevin Chiem, Luis Jimenez-Cabello, Irfan Ullah, Sergio Utrilla-Trigo, Eva Calvo-Pinilla, Gema Lorenzo, Sandra Moreno, Chengjin Ye, and et al. 2023. "Vaccinia Virus Strain MVA Expressing a Prefusion-Stabilized SARS-CoV-2 Spike Glycoprotein Induces Robust Protection and Prevents Brain Infection in Mouse and Hamster Models" Vaccines 11, no. 5: 1006. https://doi.org/10.3390/vaccines11051006

Lorenzo, M. M., Marín-López, A., Chiem, K., Jimenez-Cabello, L., Ullah, I., Utrilla-Trigo, S., Calvo-Pinilla, E., Lorenzo, G., Moreno, S., Ye, C., Park, J.-G., Matía, A., Brun, A., Sánchez-Puig, J. M., Nogales, A., Mothes, W., Uchil, P. D., Kumar, P., Ortego, J., ... Blasco, R. (2023). Vaccinia Virus Strain MVA Expressing a Prefusion-Stabilized SARS-CoV-2 Spike Glycoprotein Induces Robust Protection and Prevents Brain Infection in Mouse and Hamster Models. Vaccines, 11(5), 1006. https://doi.org/10.3390/vaccines11051006